BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30385254)

  • 21. Improved serotonergic neurotransmission by genistein pretreatment regulates symptoms of obsessive-compulsive disorder in streptozotocin-induced diabetic mice.
    Phadnis P; Dey Sarkar P; Rajput MS
    J Basic Clin Physiol Pharmacol; 2018 Jul; 29(4):421-425. PubMed ID: 29561730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of the sigma1 receptor in inhibiting activity of fluvoxamine on marble-burying behavior: comparison with paroxetine.
    Egashira N; Harada S; Okuno R; Matsushita M; Nishimura R; Mishima K; Iwasaki K; Orito K; Fujiwara M
    Eur J Pharmacol; 2007 Jun; 563(1-3):149-54. PubMed ID: 17349995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short or moderate-time exposure to the inhalational anesthetics isoflurane and sevoflurane does not alter the marble-burying behavior in mice.
    Rocha TG; Tosta CL; Herbst LS; Beijamini V
    Neurosci Lett; 2020 Jun; 729():135018. PubMed ID: 32360933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ketamine and aminoguanidine differentially affect Bdnf and Mtor gene expression in the prefrontal cortex of adult male rats.
    Silva Pereira V; Elfving B; Joca SRL; Wegener G
    Eur J Pharmacol; 2017 Nov; 815():304-311. PubMed ID: 28947331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
    J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of ritanserin and leuprolide alone and combined on marble-burying behavior of mice.
    Gaikwad U; Parle M; Kumar A; Gaikwad D
    Acta Pol Pharm; 2010; 67(5):523-7. PubMed ID: 20873421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aripiprazole inhibits marble-burying behavior via 5-hydroxytryptamine (5-HT)1A receptor-independent mechanisms.
    Egashira N; Okuno R; Matsushita M; Abe M; Mishima K; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 Sep; 592(1-3):103-8. PubMed ID: 18644366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
    Ren Z; Pribiag H; Jefferson SJ; Shorey M; Fuchs T; Stellwagen D; Luscher B
    Biol Psychiatry; 2016 Sep; 80(6):457-468. PubMed ID: 27062563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of mood stabilizers on marble-burying behavior in mice: involvement of GABAergic system.
    Egashira N; Abe M; Shirakawa A; Niki T; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Psychopharmacology (Berl); 2013 Mar; 226(2):295-305. PubMed ID: 23086022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hydroalcoholic extract of leaves of Colocasia esculenta on marble-burying behavior in mice: Implications for obsessive-compulsive disorder.
    Kalariya M; Prajapati R; Parmar SK; Sheth N
    Pharm Biol; 2015 Aug; 53(8):1239-42. PubMed ID: 25885941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test.
    Ostadhadi S; Ahangari M; Nikoui V; Norouzi-Javidan A; Zolfaghari S; Jazaeri F; Chamanara M; Akbarian R; Dehpour AR
    Biomed Pharmacother; 2016 Aug; 82():713-21. PubMed ID: 27470415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketamine-like effects of a combination of olanzapine and fluoxetine on AMPA and NMDA receptor-mediated transmission in the medial prefrontal cortex of the rat.
    Björkholm C; Jardemark K; Schilström B; Svensson TH
    Eur Neuropsychopharmacol; 2015 Oct; 25(10):1842-7. PubMed ID: 26233606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased serotonergic neurotransmission is not responsible for the anticompulsive effect of berberine in a murine model of obsessive-compulsive disorder.
    Dixit PV; Parihar G; Jain DK; Jaiswal P
    Behav Pharmacol; 2012 Oct; 23(7):716-21. PubMed ID: 22890212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurosteroids modulate compulsive and persistent behavior in rodents: implications for obsessive-compulsive disorder.
    S N U; J M V; N S J; P V D
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1161-6. PubMed ID: 19549549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.
    Hou Y; Zhang H; Xie G; Cao X; Zhao Y; Liu Y; Mao Z; Yang J; Wu C
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():107-16. PubMed ID: 23603358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT 2A receptor antagonistic activity, on a marble-burying behavior test as an obsessive-compulsive disorder model.
    Takeuchi H; Yatsugi S; Yamaguchi T
    Jpn J Pharmacol; 2002 Oct; 90(2):197-200. PubMed ID: 12419892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of ketamine and N-methyl-D-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test.
    Owolabi RA; Akanmu MA; Adeyemi OI
    Neurosci Lett; 2014 Apr; 566():172-6. PubMed ID: 24530380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of 3-oxypyridine and succinic acid derivatives on obsessive-compulsive activity of mice in marble-burying test].
    Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Faĭzullin RM; Priakhina KE
    Eksp Klin Farmakol; 2014; 77(10):10-4. PubMed ID: 25518521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prodrug 4-Chlorokynurenine Causes Ketamine-Like Antidepressant Effects, but Not Side Effects, by NMDA/GlycineB-Site Inhibition.
    Zanos P; Piantadosi SC; Wu HQ; Pribut HJ; Dell MJ; Can A; Snodgrass HR; Zarate CA; Schwarcz R; Gould TD
    J Pharmacol Exp Ther; 2015 Oct; 355(1):76-85. PubMed ID: 26265321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.